Showing results (801-810 of 6,303) with videos related to

Sort By:
Pageof 631
Diabetes, Obesity & Metabolism|February 15, 2019
Uric acid and the cardio-renal effects of SGLT2 inhibitorsClifford J Bailey
Diabetes, Obesity & Metabolism|August 18, 2017
Single-dose euglycaemic clamp studies demonstrating pharmacokinetic and pharmacodynamic similarity between MK-1293 insulin glargine and originator insulin glargine (Lantus) in subjects with type 1 diabetes and healthy subjectsMichael F Crutchlow, John S Palcza, Kate M Mostoller, et al.
Diabetes, Obesity & Metabolism|March 24, 2018
Comparative efficacy and safety of the duodenal-jejunal bypass liner in obese patients with type 2 diabetes mellitus: A case control studyKatharina Laubner, Nina Riedel, Katharina Fink, et al.
Diabetes, Obesity & Metabolism|March 25, 2018
Longitudinal medical resources and costs among type 2 diabetes patients participating in the Trial Evaluating Cardiovascular Outcomes with Sitagliptin (TECOS)Shelby D Reed, Yanhong Li, Jose Leal, et al.
Diabetes, Obesity & Metabolism|February 9, 2019
Association between allopurinol and cardiovascular outcomes and all-cause mortality in diabetes: A retrospective, population-based cohort studyAlanna Weisman, George A Tomlinson, Lorraine L Lipscombe, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Anti-interleukin-1 therapy has mild hypoglycaemic effect in type 2 diabetesJinya Huang, Yehong Yang, Renming Hu, et al.
Diabetes, Obesity & Metabolism|October 27, 2017
Targeting postprandial glycaemia in children with diabetes: Opportunities and challengesMyfanwy C Geyer, Christopher K Rayner, Michael Horowitz, et al.
Diabetes, Obesity & Metabolism|February 6, 2018
Elevations of metabolic risk factors 20 years or more before diagnosis of type 2 diabetes: Experience from the AMORIS studyHåkan Malmström, Göran Walldius, Sofia Carlsson, et al.
Diabetes, Obesity & Metabolism|January 25, 2018
Efficacy of glucagon-like peptide-1 receptor agonists compared to dipeptidyl peptidase-4 inhibitors for the management of type 2 diabetes: A meta-analysis of randomized clinical trialsSusan Tran, Ravi Retnakaran, Bernard Zinman, et al.
Diabetes, Obesity & Metabolism|January 30, 2018
Two-year trial of intermittent insulin therapy vs metformin for the preservation of β-cell function after initial short-term intensive insulin induction in early type 2 diabetesRavi Retnakaran, Haysook Choi, Chang Ye, et al.
Pageof 631